Challenges in optimizing the treatment of Pneumocystis pneumonia in the intensive care unit. Author's reply
Intensive Care Med
.
2024 Oct;50(10):1721-1722.
doi: 10.1007/s00134-024-07592-4.
Epub 2024 Aug 15.
Authors
Toufik Kamel
1
,
Oliver Guisset
2
,
Pierre Fillatre
3
,
Xavier Valette
4
,
Thierry Boulain
5
Affiliations
1
Médecine intensive-Réanimation, Centre Hospitalier Universitaire d'Orléans, 14 Avenue de L'Hôpital CS 86709, 45067, Orleans Cedex 2, France.
2
Médecine intensive-Réanimation, Centre Hospitalier Universitaire -SAINT-ANDRE, 1 Rue Jean Burguet, 33075, Bordeaux, France.
3
Réanimation Polyvalente, Centre Hospitalier Yves-Le Foll, 10, Rue Marcel Proust, 22000, Saint Brieuc, France.
4
Médecine intensive-Réanimation, Centre Hospitalier Universitaire de Caen Normandie, 14000, Caen, France.
5
Médecine intensive-Réanimation, Centre Hospitalier Universitaire d'Orléans, 14 Avenue de L'Hôpital CS 86709, 45067, Orleans Cedex 2, France.
[email protected]
.
PMID:
39145788
DOI:
10.1007/s00134-024-07592-4
No abstract available
Publication types
Letter
MeSH terms
Antifungal Agents / therapeutic use
Humans
Intensive Care Units* / organization & administration
Pneumocystis carinii
Pneumonia, Pneumocystis* / drug therapy
Substances
Antifungal Agents